GLOBAL IBS-C DRUG MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Nov 2018 135

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

IBS-C is defined as belly pain (abdominal pain) associated with constipation. The symptoms of IBS-C are defined as long-lasting and keep coming back. Those suffering from IBS-C also have hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time.

Scope of the Report:

The important driver increasing growth in the Global Irritable Bowel Syndrome with Constipation drugs Market are modern dietary habits that are having adverse effects on the human body. Some of the dietary habits leading to constipation include high intake of foods like insoluble fiber, grains, milk, fried foods, etc. Excessive intake of caffeine and alcohol increases excretion, and this loss of water through urination can also lead to IBS.

The worldwide market for IBS-C Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the IBS-C Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Catalent Pharmaceuticals Solutions
- Nestle
- Abbott Laboratories
- Synergy Pharmaceuticals
- Sucampo Pharmaceuticals
- Novartis Pharma
- Astellas Pharmaceuticals
- Ardelyx
- Synthetic Biologics
- Teva Pharmaceutical Industries
- Bama-Geve
- Ferring BV
- Ironwood Pharmaceuticals
- Salix Pharmaceuticals
- Norgine
- Prometheus Laboratories
- Actavis Nordic
- Albireo Pharma
- Yuhan Corp
- Astrazeneca
- The Menarini Group
- Ono Pharmaceutical

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Linaclotide
- Lubiprostone
- Osmotic Laxatives
- Stimulant Laxatives
- Other

Market Segment by Applications, can be divided into
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

There are 15 Chapters to deeply display the global IBS-C Drug market.

Chapter 1, to describe IBS-C Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of IBS-C Drug, with sales, revenue, and price of IBS-C Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of IBS-C Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, IBS-C Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe IBS-C Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Dec 19)

Description Scope of the Report: The worldwide market for Sublingual Sprays is expected to grow at a CAGR of roughly x...

(Dec 19)

Description Scope of the Report: The global Iloprost Drugs market is valued at 97.8 million USD in 2018 and is expecte...

(Dec 19)

Description Scope of the Report: The worldwide market for Treprostinil Drugs is expected to grow at a CAGR of roughly ...

(Dec 19)

Description Scope of the Report: The worldwide market for Swine Reproductive and Respiratory Syndrome Vaccine is expec...

(Dec 19)

Description Scope of the Report: The worldwide market for East Africa and Turkey Heart Failure Drugs is expected to gr...

(Dec 19)

Description Scope of the Report: The worldwide market for Panax Quinquefolius is expected to grow at a CAGR of roughly...

GLOBAL IBS-C DRUG MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy